DOI: 10.1002/pd.4440
EDITORIAL
The 2013 Malcolm Ferguson-Smith Young Investigator Award Diana W. Bianchi1, Lyn S. Chitty2, Jan Deprest3, Brigitte H. W. Faas4, Alessandro Ghidini5 and Rupert K. J. Cousens6* 1
Tufts Medical Center, Boston, USA University College London NHS Foundation Trust, London, UK 3 University Hospital Gasthuisberg, Leuven, Belgium 4 Radboud University Medical Centre, Nijmegen, The Netherlands 5 Georgetown University Hospital, Washington DC, USA 6 John Wiley & Sons, Oxford, UK *Correspondence to: Rupert Cousens. E-mail: [email protected] 2
Figure 1 Dr Amy Metcalfe, winner of the 2013 Malcolm FergusonSmith Young Investigator Award
In recognition of Prenatal Diagnosis’ Founding Editor, Professor Malcolm Ferguson-Smith, the Young Investigator Award honours the best articles published in the journal during the prior calendar year in which the first author is under the age of 40 years. The Editors of Prenatal Diagnosis are delighted to announce that Dr. Amy Metcalfe (Figure 1) from Department of Obstetrics and Gynaecology, University of British Columbia, Canada has been awarded the 2013 Award for her paper entitled ‘Impact of observed versus hypothesized service utilization on the incremental cost of first trimester screening and prenatal diagnosis for trisomy 21 in a Canadian province’. The Editors were pleased to receive many worthy nominations for the 2013 Award. From these nominations, a ‘short list’ of five papers was further considered for the award. Accordingly, in addition to the winner, the editors highly commended four other papers that are listed in Table 1. Previous winners of the Award are shown in Table 2. Dr. Metalfe receives a cheque for $2000 and an invitation to orally present her research at the 2014 ISPD meeting in Brisbane. Details regarding the nomination of papers published in 2014 for the next Malcolm Ferguson-Smith Young Investigator prize will be provided in early 2015.
Table 1 The 2013 Malcolm Ferguson-Smith Award: winning and highly commended authors and articles First author
Article title
WINNER Amy Metcalfe, Canada
Impact of observed versus hypothesized service utilization on the incremental cost of first trimester screening and prenatal diagnosis for trisomy 21 in a Canadian province1
HIGHLY COMMENDED (alphabetical order) Christina Alamillo, USA
Nearly a third of abnormalities found after first trimester screening are different than expected:10-year experience from a single center2
Ai Higashijima, Japan
Characterization of placenta-specific microRNAs in fetal growth restriction pregnancy3
Tülay Özlü, Turkey
Fetal isolated short femur in the second trimester and adverse pregnancy outcomes4
Silvia Zia, Belgium
Routine clonal expansion of mesenchymal stem cells derived from amniotic fluid for perinatal applications5
Prenatal Diagnosis 2014, 34, 717–718
© 2014 John Wiley & Sons, Ltd.
Editorial
718
Table 2 Previous winners of the Malcolm Ferguson-Smith Award Year
First author
Article title
2012
Marie Brinch, Denmark
Identification of circulating fetal cell markers by microarray analysis6
2011
Jeroen L. A. Pennings, Netherlands
Integrative data mining to identify novel candidate serum biomarkers for pre-eclampsia screening7
2010
JérômeToutain, France
Confined placental mosaicism and pregnancy outcome: a distinction needs to be made between types 2 and 38
2009
Tianjiao Chu, USA
A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease9
2008
Olivier Picone, France
Comparison between ultrasound and magnetic resonance imaging in assessment of fetal cytomegalovirus infection10
2007
Nicholas J. Cowans, UK
First trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system11
REFERENCES 1. Metcalfe A, Currie G, Johnson J-A, et al. Impact of observed versus hypothesized service utilization on the incremental cost of first trimester screening and prenatal diagnosis for trisomy 21 in a Canadian province. Prenat Diagn 2013;33:429–35. doi: 10.1002/ pd.4082 2. Alamillo CML, Krantz D, Evans M, et al. Nearly a third of abnormalities found after first-trimester screening are different than expected:10-year experience from a single center. Prenat Diagn 2013;33:251–6. doi: 10.1002/pd.4054 3. Higashijima A, Miura K, Mishima H, et al. Characterization of placentaspecific microRNAs in fetal growth restriction pregnancy. Prenat Diagn 2013;33:214–22. doi: 10.1002/pd.4045 4. Özlü T, Ozcan T. Fetal isolated short femur in the second trimester and adverse pregnancy outcomes. Prenat Diagn 2013;33:1063–9. doi: 10.1002/pd.4197 5. Zia S, Toelen J, Mori da Cunha M, et al. Routine clonal expansion of mesenchymal stem cells derived from amniotic fluid for perinatal applications. Prenat Diagn 2013;33:921–8. doi: 10.1002/ pd.4162
Prenatal Diagnosis 2014, 34, 717–718
6. Brinch M, Hatt L, Singh R, et al. Identification of circulating fetal cell markers by microarray analysis. Prenat Diagn 2012;32:742–51. doi: 10.1002/pd.3894 7. Pennings JLA, Kuc S, Rodenburg W, et al. Integrative data mining to identify novel candidate serum biomarkers for pre-eclampsia screening. Prenat Diagn 2011;31:1153–9. doi: 10.1002/pd.2850 8. Toutain J, Labeau-Gaüzere C, Barnetche T, et al. Confined placental mosaicism and pregnancy outcome: a distinction needs to be made between types 2 and 3. Prenat Diagn 2010;30:1155–64. doi: 10.1002/pd.2631 9. Chu T, Burke B, Bunce K, et al. A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease. Prenat Diagn 2009;29:1020–30. doi:10.1002/pd.2335 10. Picone O, Simon I, Benachi A, et al. Comparison between ultrasound and magnetic resonance imaging in assessment of fetal cytomegalovirus infection. Prenat Diagn 2008;28:753–8. doi: 10.1002/pd.2037 11. Cowans NJ, Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn 2007;27:264–71. doi: 10.1002/pd.1665
© 2014 John Wiley & Sons, Ltd.
EDITORIAL
The 2013 Malcolm Ferguson-Smith Young Investigator Award Diana W. Bianchi1, Lyn S. Chitty2, Jan Deprest3, Brigitte H. W. Faas4, Alessandro Ghidini5 and Rupert K. J. Cousens6* 1
Tufts Medical Center, Boston, USA University College London NHS Foundation Trust, London, UK 3 University Hospital Gasthuisberg, Leuven, Belgium 4 Radboud University Medical Centre, Nijmegen, The Netherlands 5 Georgetown University Hospital, Washington DC, USA 6 John Wiley & Sons, Oxford, UK *Correspondence to: Rupert Cousens. E-mail: [email protected] 2
Figure 1 Dr Amy Metcalfe, winner of the 2013 Malcolm FergusonSmith Young Investigator Award
In recognition of Prenatal Diagnosis’ Founding Editor, Professor Malcolm Ferguson-Smith, the Young Investigator Award honours the best articles published in the journal during the prior calendar year in which the first author is under the age of 40 years. The Editors of Prenatal Diagnosis are delighted to announce that Dr. Amy Metcalfe (Figure 1) from Department of Obstetrics and Gynaecology, University of British Columbia, Canada has been awarded the 2013 Award for her paper entitled ‘Impact of observed versus hypothesized service utilization on the incremental cost of first trimester screening and prenatal diagnosis for trisomy 21 in a Canadian province’. The Editors were pleased to receive many worthy nominations for the 2013 Award. From these nominations, a ‘short list’ of five papers was further considered for the award. Accordingly, in addition to the winner, the editors highly commended four other papers that are listed in Table 1. Previous winners of the Award are shown in Table 2. Dr. Metalfe receives a cheque for $2000 and an invitation to orally present her research at the 2014 ISPD meeting in Brisbane. Details regarding the nomination of papers published in 2014 for the next Malcolm Ferguson-Smith Young Investigator prize will be provided in early 2015.
Table 1 The 2013 Malcolm Ferguson-Smith Award: winning and highly commended authors and articles First author
Article title
WINNER Amy Metcalfe, Canada
Impact of observed versus hypothesized service utilization on the incremental cost of first trimester screening and prenatal diagnosis for trisomy 21 in a Canadian province1
HIGHLY COMMENDED (alphabetical order) Christina Alamillo, USA
Nearly a third of abnormalities found after first trimester screening are different than expected:10-year experience from a single center2
Ai Higashijima, Japan
Characterization of placenta-specific microRNAs in fetal growth restriction pregnancy3
Tülay Özlü, Turkey
Fetal isolated short femur in the second trimester and adverse pregnancy outcomes4
Silvia Zia, Belgium
Routine clonal expansion of mesenchymal stem cells derived from amniotic fluid for perinatal applications5
Prenatal Diagnosis 2014, 34, 717–718
© 2014 John Wiley & Sons, Ltd.
Editorial
718
Table 2 Previous winners of the Malcolm Ferguson-Smith Award Year
First author
Article title
2012
Marie Brinch, Denmark
Identification of circulating fetal cell markers by microarray analysis6
2011
Jeroen L. A. Pennings, Netherlands
Integrative data mining to identify novel candidate serum biomarkers for pre-eclampsia screening7
2010
JérômeToutain, France
Confined placental mosaicism and pregnancy outcome: a distinction needs to be made between types 2 and 38
2009
Tianjiao Chu, USA
A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease9
2008
Olivier Picone, France
Comparison between ultrasound and magnetic resonance imaging in assessment of fetal cytomegalovirus infection10
2007
Nicholas J. Cowans, UK
First trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system11
REFERENCES 1. Metcalfe A, Currie G, Johnson J-A, et al. Impact of observed versus hypothesized service utilization on the incremental cost of first trimester screening and prenatal diagnosis for trisomy 21 in a Canadian province. Prenat Diagn 2013;33:429–35. doi: 10.1002/ pd.4082 2. Alamillo CML, Krantz D, Evans M, et al. Nearly a third of abnormalities found after first-trimester screening are different than expected:10-year experience from a single center. Prenat Diagn 2013;33:251–6. doi: 10.1002/pd.4054 3. Higashijima A, Miura K, Mishima H, et al. Characterization of placentaspecific microRNAs in fetal growth restriction pregnancy. Prenat Diagn 2013;33:214–22. doi: 10.1002/pd.4045 4. Özlü T, Ozcan T. Fetal isolated short femur in the second trimester and adverse pregnancy outcomes. Prenat Diagn 2013;33:1063–9. doi: 10.1002/pd.4197 5. Zia S, Toelen J, Mori da Cunha M, et al. Routine clonal expansion of mesenchymal stem cells derived from amniotic fluid for perinatal applications. Prenat Diagn 2013;33:921–8. doi: 10.1002/ pd.4162
Prenatal Diagnosis 2014, 34, 717–718
6. Brinch M, Hatt L, Singh R, et al. Identification of circulating fetal cell markers by microarray analysis. Prenat Diagn 2012;32:742–51. doi: 10.1002/pd.3894 7. Pennings JLA, Kuc S, Rodenburg W, et al. Integrative data mining to identify novel candidate serum biomarkers for pre-eclampsia screening. Prenat Diagn 2011;31:1153–9. doi: 10.1002/pd.2850 8. Toutain J, Labeau-Gaüzere C, Barnetche T, et al. Confined placental mosaicism and pregnancy outcome: a distinction needs to be made between types 2 and 3. Prenat Diagn 2010;30:1155–64. doi: 10.1002/pd.2631 9. Chu T, Burke B, Bunce K, et al. A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease. Prenat Diagn 2009;29:1020–30. doi:10.1002/pd.2335 10. Picone O, Simon I, Benachi A, et al. Comparison between ultrasound and magnetic resonance imaging in assessment of fetal cytomegalovirus infection. Prenat Diagn 2008;28:753–8. doi: 10.1002/pd.2037 11. Cowans NJ, Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn 2007;27:264–71. doi: 10.1002/pd.1665
© 2014 John Wiley & Sons, Ltd.
